skip to main | skip to sidebar

The Health, Drug, Prescription, and GMP Supersite

Thoughts and resources about health, drugs and prescriptions, and how they are affected by GMPs (FDA Good Manufacturing Practices) and other regulations.

Thursday, January 17, 2013

Know What To Do About The Flu

Take action now!

Flu: What To Do If You Get Sick - CDC.gov

Return Home: The Health, Drug, Prescription, and GMP Supersite Blog

SkillsPlus Intl Inc. - The best GMP training, best QSR training, best instructors
SkillsPlus Intl Info Blog
The Exemptee Institute
The Designated Representative Institute
The Health, Drug, Prescription, and GMP Supersite Gift Store 

Email ThisBlogThis!Share to XShare to FacebookShare to Pinterest
Posted by Austin Lee at 1:49 PM
Labels: flu, free, influenza, prevention, recommendations, suggestions, tips, treatment

No comments:

Post a Comment

Newer Post Older Post Home
Subscribe to: Post Comments (Atom)

From SkillsPlus International Inc.

Loading...
  • Home
  • SkillsPlus Intl Inc - The Leader in QSR & GMP Training
  • Popular FDA, cGMP, QSR, & GMP Training Courses
  • The Best Exemptee & Designated Representative Training Courses - Online Self-Study
  • CA HMDR Exemptee Certification Class
  • California Exemptee Certification - State Approved
  • The Exemptee Institute
  • The Designated Representative Institute
  • SkillsPlus Intl Inc Blog
  • Home Medical Device Retail - California HMDR Exemptee Training Certification Course
  • Designated Representative Online Training Courses

California Designated Representative Training


Designated Representative Wholesaler Training Course

Designated Representative 3PL Training Course

Designated Representative Reverse Distributor Course


SkillsPlus International Inc. is the ONLY training provider approved by the California State Board of Pharmacy to offer California Designated Representative training programs for wholesalers, 3PL, and reverse distributors. Nearly 10,000 students have taken our state license-related training courses! #2025 #2026 #2027

CA Designated Rep 3PL Course

CA Designated Rep 3PL Course
California Designated Representative 3PL Online Training Course. #2025

The Best Exemptee Training



Sign-up for Exemptee training now!


California HMDR Exemptee license online training certification class for home medical device retailers. Earns a course completion certificate accepted by the California Department of Public Health - Food and Drug Branch. We've added something new, closed captioning. Students can read what the course instructor is teaching. Nearly 10,000 students have taken our state license-related training courses! This feature helps ESL (English as a second language) students, and hard of hearing students. #2025 #2026 #2027

CGMP Online Training Courses

CGMP Online Training Courses
Current Good Manufacturing Practice Training: A New Generation Series - CGMP Online Courses

GMP Trainer Courses

GMP Trainer Courses
GMP Trainer Awareness, Certification, and Master Trainer Courses

Root Cause Analysis - cGMP Training

Root Cause Analysis - cGMP Training
cGMP Training - Online Self-Study Course - Root Cause - Investigation Reports

Subscribe To

Posts
Atom
Posts
Comments
Atom
Comments
Subscribe to The Health, Drug, Prescription, and GMP Supersite by Email

Blog List

  • FierceBiotech
    Alcon to buy LumiThera’s light-based therapy for dry AMD
    9 minutes ago
  • eLearning Industry
    Brand Monitoring Made Easy: 5 Ways To Track Brand Mentions And Safeguard Your Reputation
    2 hours ago
  • Medscape Today Headlines
    Common Cold Virus Infections Drop After SARS-CoV-2 Exposure
    3 hours ago
  • Clarkston Consulting
    How Luxury Retailers Are Evolving to Meet the Needs of the Conscious Consumer
    3 hours ago
  • Medtech Insight
    Thena Capital’s New Fund Up And Running With £1M Investment In Plexāā’s Breast Cancer Device
    4 hours ago
  • GEN Biotech News
    “In-Region, For Region”: Cytiva Builds Out $1.6B in Global Expansion Projects
    4 hours ago
  • Government Executive
    Schumer requests probe into impact of staffing cuts on Texas flood response
    4 hours ago
  • Pharmaceutical Commerce
    What Payers Really Want from High Cost Therapies in Rare Diseases
    4 hours ago
  • BioPharma Dive - Latest News
    Protein degraders: chasing undruggable targets
    4 hours ago
  • BioPharma Dive
    Protein degraders: chasing undruggable targets
    4 hours ago
  • Drug Channels
    The Stelara Biosimilar Price War: How PBM-Affiliated Private Labels Are Reshaping the Market
    4 hours ago
  • Pharmafile
    Duke Street Bio receives FDA fast track designation for brain metastases treatment
    5 hours ago
  • Drug & Device Law
    Commonality Isn’t King
    5 hours ago
  • Wellness Blog - NY Times
    Sweden’s Secret to Well-Being? Tiny Urban Gardens.
    6 hours ago
  • NPR Blogs: Shots - Health News Blog
    RFK Jr.'s vaccine policy sparks a lawsuit from the American Academy of Pediatrics
    6 hours ago
  • All Kaiser Health News
    In a Nation Growing Hostile Toward Drugs and Homelessness, Los Angeles Tries Leniency
    6 hours ago
  • JD Supra Law News
    DOJ and HHS Launch Enhanced False Claims Act Working Group: Heightened Enforcement Ahead for Key Healthcare Sectors
    9 hours ago
  • FierceBiotech: Medtech
    Boston Scientific expands Farapulse’s reach in afib with new FDA approval
    21 hours ago
  • Mobihealthnews
    WakeMed Health gains $10M with AI documentation and clinical insights system
    21 hours ago
  • Healthcare Packaging
    Study Reveals the U.S. Pharmaceutical Firms with the Most FDA Recalls
    1 day ago
  • Pharmalot – STAT
    STAT+: Pharmalittle: We’re reading about FDA morale, a U.S.-Swiss trade deal on pharma levies, and more
    1 day ago
  • Pharmafile - Mfg & Production
    LEO Pharma appoints Helle Hedegaard Juhl as EVP of global people & corporate affairs
    1 day ago
  • FiercePharma
    Provider groups sue RFK Jr. to roll back COVID-19 vaccine recommendation changes
    1 day ago
  • Science-Based Medicine
    After ACIP: Where Robert F. Kennedy Jr. will likely go from here in his quest to eliminate vaccines
    1 day ago
  • Food Poison Journal
    Hey, RFK, what if this was one of your family?
    2 days ago
  • Marler Blog
    Come on RFK, Live up to your Hype – Radical Transparancy
    3 days ago
  • FDA What's New: Drugs
    Exela Pharma Sciences, LLC - 709859 - 07/02/2025
    5 days ago
  • CNBC Health Care
    Healthy Returns: What to know about a CDC vaccine panel's votes against a mercury preservative in flu shots
    6 days ago
  • The Incidental Economist
    Older Americans Backing Trump Now Face Cuts to Medicaid, Services
    1 week ago
  • FDA - Press Releases
    FDA Eliminates Risk Evaluation and Mitigation Strategies (REMS) for Autologous Chimeric Antigen Receptor CAR T cell Immunotherapies
    1 week ago
  • World Pharma - Breaking News
    Penn engineers turn toxic fungus into anti-cancer compound
    1 week ago
  • Asbestos and Mesothelioma News
    Asbestos Ban Future Is Uncertain
    1 week ago
  • Clinical Correlations
    How Can We Better Protect Our Patients Against Extreme Heat?
    2 weeks ago
  • Ted Eytan, MD
    Nova Exhibition
    2 weeks ago
  • The Compliance and Ethics Blog
    Mark Diamond on Rethinking Records Retention [Podcast]
    3 weeks ago
  • SkillsPlus International Info
    FDA Rushed Out AI Tool
    4 weeks ago
  • The Health, Drug, Prescription, and GMP Supersite
    Designated Representative Training - California | State-Approved
    4 weeks ago
  • Modern Healthcare News
    Meet the Administration for a Healthy America, HHS' newest agency
    4 weeks ago
  • Quality Matters
    A path to locally manufactured quality medicines: Building capacity in Africa to conduct bioequivalence studies
    1 month ago
  • Designated Representative and Exemptee
    Designated Representative Training | Board-Approved Courses | Recommended
    3 months ago
  • Pharma IQ Regulatory-Legal
    AI-Driven Productivity Gains: Transforming Pharma Supply Chain Efficiency
    4 months ago
  • FDA – Policy & Medicine
    FDA Releases Draft Guidance on the Accelerated Approval Process
    4 months ago
  • BioPharma-Reporter RSS
    Inhibikase to pause development of Parkinson’s drug
    5 months ago
  • Outsourcing-Pharma
    Ethris reports positive phase 1 results for asthma mRNA therapy
    5 months ago
  • Outsourcing-Pharma
    Ethris reports positive phase 1 results for asthma mRNA therapy
    5 months ago
  • 33 Charts
    AI and LinkedIn Writing as a Commodity
    5 months ago
  • Biotech Blog
    Making Medicines Affordable: The Role of Generics
    6 months ago
  • FDA - Health Fraud
    27 Individuals Indicted for Buying and Selling Wholesale Quantities of Misbranded and Diverted Prescription Drugs Resold to the Public Through Retail Pharmacies in Puerto Rico
    9 months ago
  • BioSpace Regulatory News
    FDA Questions Strength of Evidence Backing Zevra’s Rare Disease Therapy Ahead of Adcomm
    11 months ago
  • Healthy Travel Blog
    Hello world!
    1 year ago
  • Quality Digest - FDA Compliance
    Nine Strategies for Effective Internal Audits
    1 year ago
  • Eye on FDA
    FDA Adds New AdComm to Address Genetic Metabolic Diseases
    1 year ago
  • Designated Representative Training Courses
    The Only Board-Approved California Designated Representative Training Programs For ...
    1 year ago
  • HMDR Exemptee Online Training
    California HMDR Exemptee Online Training Certification Course
    1 year ago
  • Medgadget
    Plant-Based Soft Medical Robots
    1 year ago
  • Drug Injury Watch
    Ozempic / Wegovy: Stomach And Intestinal Problems Can Be Irreversible, Life-threatening
    1 year ago
  • Golf Foodie
    More women in the U.S. are drinking themselves to death, research finds
    1 year ago
  • PharmaPhorum News
    Patient adherence – the key to restoring trust in pharma
    2 years ago
  • Pharma Manufacturing
    How pharma can overcome inflation
    2 years ago
  • Pharmaceutical Industry | Processing & Engineering: Knowledge, News and Analysis | Pharmaceutical Manufacturing
    How pharma can overcome inflation
    2 years ago
  • CA Designated Rep Training
    Recommended! California Designated Representative Online Training Courses
    5 years ago
Show 5 Show All

Blog Archive

  • ►  2025 (1)
    • ►  June (1)
  • ►  2024 (5)
    • ►  August (1)
    • ►  July (1)
    • ►  May (1)
    • ►  March (2)
  • ►  2023 (6)
    • ►  December (1)
    • ►  October (2)
    • ►  July (1)
    • ►  May (1)
    • ►  January (1)
  • ►  2022 (26)
    • ►  November (3)
    • ►  October (1)
    • ►  August (2)
    • ►  July (3)
    • ►  June (4)
    • ►  May (3)
    • ►  April (3)
    • ►  March (1)
    • ►  February (3)
    • ►  January (3)
  • ►  2021 (17)
    • ►  December (2)
    • ►  November (2)
    • ►  October (2)
    • ►  September (2)
    • ►  July (1)
    • ►  April (1)
    • ►  March (1)
    • ►  February (2)
    • ►  January (4)
  • ►  2020 (27)
    • ►  December (5)
    • ►  November (2)
    • ►  October (1)
    • ►  September (4)
    • ►  August (2)
    • ►  July (2)
    • ►  June (2)
    • ►  May (1)
    • ►  April (1)
    • ►  March (2)
    • ►  February (5)
  • ►  2019 (28)
    • ►  December (5)
    • ►  November (2)
    • ►  October (1)
    • ►  September (2)
    • ►  August (3)
    • ►  July (6)
    • ►  June (3)
    • ►  May (2)
    • ►  April (1)
    • ►  February (3)
  • ►  2018 (6)
    • ►  October (1)
    • ►  August (1)
    • ►  July (1)
    • ►  June (1)
    • ►  May (1)
    • ►  January (1)
  • ►  2017 (14)
    • ►  November (1)
    • ►  October (2)
    • ►  August (1)
    • ►  July (1)
    • ►  May (2)
    • ►  April (1)
    • ►  March (1)
    • ►  January (5)
  • ►  2016 (32)
    • ►  December (6)
    • ►  November (4)
    • ►  October (2)
    • ►  September (2)
    • ►  August (2)
    • ►  July (3)
    • ►  June (1)
    • ►  May (3)
    • ►  March (4)
    • ►  February (2)
    • ►  January (3)
  • ►  2015 (68)
    • ►  December (2)
    • ►  November (7)
    • ►  October (10)
    • ►  September (5)
    • ►  August (1)
    • ►  July (6)
    • ►  June (7)
    • ►  May (5)
    • ►  April (3)
    • ►  March (3)
    • ►  February (13)
    • ►  January (6)
  • ►  2014 (105)
    • ►  December (10)
    • ►  November (9)
    • ►  October (1)
    • ►  September (9)
    • ►  August (4)
    • ►  July (6)
    • ►  June (11)
    • ►  May (10)
    • ►  April (10)
    • ►  March (11)
    • ►  February (15)
    • ►  January (9)
  • ▼  2013 (127)
    • ►  December (7)
    • ►  November (14)
    • ►  October (7)
    • ►  September (11)
    • ►  August (7)
    • ►  July (9)
    • ►  June (9)
    • ►  May (6)
    • ►  April (8)
    • ►  March (22)
    • ►  February (9)
    • ▼  January (18)
      • DOJ - Compliance - Ask Yourself These 5 Questions
      • FDA Warning - GermBullet Is An Unapproved Flu Remedy
      • ACIP - 2013 Adult Immunization Schedule
      • FDA - Foods & Veterinary Medicine Program Reorganized
      • Beware - Powerful New Norovirus Comes to the US
      • Too Little Reward For Quality - Drives Generic Inj...
      • FDA Inspection - Tips by the FDAzilla Blog
      • FDA Search for Acronyms & Abbreviations - A nice t...
      • Booze Disrupts Sleep
      • Ben Venue Signs FDA Consent Decree Over Drug Manuf...
      • FDA on Serving Up Safe Buffets
      • FDA - Pharma Warning Letters and Notice of Violati...
      • Know What To Do About The Flu
      • FDA Warning Letters - Common Violations
      • Dietary Supplement Industry - Vulnerable to FDA En...
      • FDA - Two Proposed Rules Released to Implement FSMA
      • 2012 - Top Pharma Acquisitions (AZN, BMY, GSK)
      • FDA - Food Facility Registration Renewal Deadline ...
  • ►  2012 (172)
    • ►  December (8)
    • ►  November (20)
    • ►  October (10)
    • ►  September (8)
    • ►  August (4)
    • ►  July (22)
    • ►  June (23)
    • ►  May (17)
    • ►  April (17)
    • ►  March (12)
    • ►  February (13)
    • ►  January (18)
  • ►  2011 (116)
    • ►  December (8)
    • ►  November (15)
    • ►  October (4)
    • ►  September (18)
    • ►  August (9)
    • ►  July (6)
    • ►  June (8)
    • ►  May (9)
    • ►  April (5)
    • ►  March (13)
    • ►  February (10)
    • ►  January (11)
  • ►  2010 (106)
    • ►  December (14)
    • ►  November (8)
    • ►  October (5)
    • ►  September (6)
    • ►  August (10)
    • ►  July (5)
    • ►  June (9)
    • ►  May (11)
    • ►  April (5)
    • ►  March (11)
    • ►  February (10)
    • ►  January (12)
  • ►  2009 (192)
    • ►  December (11)
    • ►  November (11)
    • ►  October (15)
    • ►  September (13)
    • ►  August (10)
    • ►  July (19)
    • ►  June (16)
    • ►  May (16)
    • ►  April (17)
    • ►  March (16)
    • ►  February (19)
    • ►  January (29)
  • ►  2008 (245)
    • ►  December (32)
    • ►  November (39)
    • ►  October (39)
    • ►  September (33)
    • ►  August (52)
    • ►  July (50)

Disclaimer & Privacy Policy

All data and information provided on this site is for informational purposes only. Drughealth.blogspot.com makes no representations as to accuracy, completeness, currentness, suitability, or validity of any information on this site and will not be liable for any errors, omissions, or delays in this information or any losses, injuries, or damages arising from its display or use. All information is provided on an as-is basis. We use third-party advertising companies to serve ads when you visit our website. These companies may use information (not including your name, address, email address, or telephone number) about your visits to this and other websites in order to provide advertisements about goods and services of interest to you. If you would like more information about this practice and to know your choices about not having this information used by these companies, click here.

SkillsPlus International Inc.

SkillsPlus International Inc.
SkillsPlus International Inc. Logo